Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...
InvestorsHub on MSN
AI healthcare and BioToken partnership expands WORK Medical’s (WOK) digital asset ambitions
WORK Medical is pushing deeper into AI-driven healthcare and digital biological asset development through a new collaboration ...
Focused on immunology-based therapies for infectious diseases, this biotech company reported a notable insider sale in recent ...
Texas farmers are not afraid of agricultural biotechnology. For over two decades, they have planted genetically engineered ...
(Michael on for Roanna Ruiz), Leerink Partners: "what would constitute a clear signal as a green light to initiate Phase III in 2027?"; President, CEO & Director De Backer: "it's going to really be ...
Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...
Fermentation has evolved from a traditional preservation method into a cornerstone of modern food innovation, where the intersection of bioprocess ...
Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will participate in a fireside chat at the Bank of America Securities 2026 ...
Is VIR a good stock to buy? We came across a bullish thesis on Vir Biotechnology, Inc. on BioEquity Watch’s Substack. In this ...
Microbial biotechnology is a dynamic field, The origins of microbiology can be traced back to the pioneering research by scientists such as Louis Pasteur and Robert Koch in the 19 th century. Within a ...
Do you want to be at the forefront of the rapidly growing biotechnology field? Do you want to develop products derived from living organisms and biomolecules? Do you have a passion for biochemistry, ...
MarketBeat on MSN
Puma Biotechnology Q1 earnings call highlights
3 small-cap biotechs with potential breakthroughs in 2024 Puma Biotechnology (NASDAQ:PBYI) reported first-quarter 2026 total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results